EPISODE · May 4, 2020 · 32 MIN
A Future Of Medicine
from Heme Review · host Chubbyemu
Support this podcast! https://anchor.fm/chubbyemu/supportVideo version of this video: https://youtu.be/iVt5BpoTHYgTweet me: https://twitter.com/HemeReviewIG me: https://instagram.com/HemeReviewMusic by Lifeformed: http://lifeformed.bandcamp.com/References:[0] Chapman PB et. al. Vemurafenib in patients with BRAFV600 mutation-positive metastatic melanoma: final overall survival results of the randomized BRIM-3 study.Ann Oncol. 2017 Oct 1;28(10):2581-2587. https://www.ncbi.nlm.nih.gov/pubmed/28961848[1] Chapman PB. Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation. N Engl J Med 2011; 364:2507-2516. https://www.nejm.org/doi/full/10.1056/NEJMoa1103782[2] Amy Harmon. New Drugs Stir Debate on Rules of Clinical Trials. New York Times, September 19, 2010. https://www.nytimes.com/2010/09/19/health/research/19trial.html
What this episode covers
Support this podcast! https://anchor.fm/chubbyemu/supportVideo version of this video: https://youtu.be/iVt5BpoTHYgTweet me: https://twitter.com/HemeReviewIG me: https://instagram.com/HemeReviewMusic by Lifeformed: http://lifeformed.bandcamp.com/References:[0] Chapman PB et. al. Vemurafenib in patients with BRAFV600 mutation-positive metastatic melanoma: final overall survival results of the randomized BRIM-3 study.Ann Oncol. 2017 Oct 1;28(10):2581-2587. https://www.ncbi.nlm.nih.gov/pubmed/28961848[1] Chapman PB. Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation. N Engl J Med 2011; 364:2507-2516. https://www.nejm.org/doi/full/10.1056/NEJMoa1103782[2] Amy Harmon. New Drugs Stir Debate on Rules of Clinical Trials. New York Times, September 19, 2010. https://www.nytimes.com/2010/09/19/health/research/19trial.html
NOW PLAYING
A Future Of Medicine
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.